BSG and neoplasm: Although no significant association was found between EMMPRIN overexpression and clinical stage, when we divided clinical stage into initial stage (I/II) tumors and advanced stage tumors (III/IV), we observed a significant association between EMMPRIN overexpression and advanced tumor stages (P = 0.015).